Humana
About: Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Employees: 67,600
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 16 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
16% more call options, than puts
Call options by funds: $2.05B | Put options by funds: $1.76B
3.34% less ownership
Funds ownership: 95.99% [Q2] → 92.65% (-3.34%) [Q3]
5% less funds holding
Funds holding: 961 [Q2] → 917 (-44) [Q3]
16% less repeat investments, than reductions
Existing positions increased: 315 | Existing positions reduced: 376
19% less capital invested
Capital invested by funds: $43.2B [Q2] → $35B (-$8.21B) [Q3]
32% less first-time investments, than exits
New positions opened: 95 | Existing positions closed: 139
44% less funds holding in top 10
Funds holding in top 10: 25 [Q2] → 14 (-11) [Q3]
Research analyst outlook
16 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$250
1%
upside
Avg. target
$278
13%
upside
High target
$395
60%
upside
16 analyst ratings
4 positive
25%
12 neutral
75%
0 negative
0%
Morgan Stanley Erin Wright 48% 1-year accuracy 11 / 23 met price target | 22%upside $301 | Equal-Weight Maintained | 17 Dec 2024 |
B of A Securities Kevin Fischbeck 54% 1-year accuracy 13 / 24 met price target | 25%upside $308 | Neutral Upgraded | 6 Nov 2024 |
TD Cowen Gary Taylor 21% 1-year accuracy 4 / 19 met price target | 8%upside $268 | Hold Maintained | 4 Nov 2024 |
Wells Fargo Stephen Baxter 20% 1-year accuracy 8 / 40 met price target | 17%upside $290 | Overweight Maintained | 4 Nov 2024 |
Barclays Andrew Mok 29% 1-year accuracy 18 / 62 met price target | 2%upside $253 | Equal-Weight Maintained | 31 Oct 2024 |
Financial journalist opinion
Based on 16 articles about HUM published over the past 30 days
Neutral
Business Wire
2 days ago
Humana Names Japan Mehta as Chief Information Officer
LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that it has named Japan Mehta as Chief Information Officer. In this role, Mehta will oversee Humana's digital and technology organization, as well as its data systems. He will also set the technology transformation vision for the company to better connect consumers to their caregivers and enable better clinical decision making, while also driving greater efficiencies through technolog.
Neutral
Business Wire
3 days ago
Texas A&M University-Mays Business School and Humana Announce Winners of Eighth Annual Healthcare Analytics Case Competition
BRYAN-COLLEGE STATION, Texas--(BUSINESS WIRE)--Texas A&M University-Mays Business School and Humana announce winners of 8th annual Healthcare Analytics Case Competition.
Neutral
Seeking Alpha
4 days ago
Humana, Cigna Plunge On Trump's Latest Promise: A Potential Buying Opportunity?
The healthcare industry, particularly PBMs, faces bipartisan scrutiny, leading to significant stock declines for Humana and Cigna, presenting a contrarian investment opportunity. President-elect Donald Trump's stance on PBMs and bipartisan legislative proposals signal potential regulatory changes, creating market uncertainty for PBM-affiliated companies. Despite recent financial setbacks, Cigna and Humana show strong revenue growth, with investment losses and rising benefit costs impacting short-term profitability.
Negative
CNBC Television
1 week ago
Senators Warren and Hawley introduce a bipartisan bill to break up pharmacy-benefit managers
CNBC's Bertha Coombs joins ‘The Exchange' to discuss a bipartisan bill introduced by Senators Elizabeth Warren and Josh Hawley aimed at breaking up pharmacy-benefit managers.
Negative
CNBC
1 week ago
Health care stocks fall as lawmakers, patients push for changes to their business models
Shares of major healthcare companies fell nearly 5% on Wednesday on concerns related to potential changes to their complex business models. That includes UnitedHealth Group, Cigna and CVS Health, which operate three of the nation's largest private health insurers and drug supply chain middlemen called pharmacy benefit managers.
Negative
Reuters
1 week ago
Health insurer stocks fall as WSJ says lawmakers set to break up pharmacy-benefit managers
Shares of health insurers such as UnitedHealth and CVS Health fell on Wednesday after a Wall Street Journal report said a bipartisan group of lawmakers were set to introduce legislation to break up pharmacy-benefit managers.
Positive
Seeking Alpha
2 weeks ago
5 Relatively Secure And Cheap Dividend Stocks For December 2024: Yields Up To 9%
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields about 3.28%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 9%.
Negative
Forbes
2 weeks ago
Health Insurance Stocks—Led By UnitedHealth—Suffer Steep Drops Following Brian Thompson's Killing
Shares of UnitedHealthcare's parent company led a broader selloff in health insurance stocks, losses one analyst described as a likely result of the industry's fresh focus following the Wednesday killing of UnitedHealthcare's chief executive Brian Thompson.
Positive
Seeking Alpha
2 weeks ago
Humana: Medicare Advantage Is Just A Short-Term Problem
Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Despite short-term cost challenges, Medicare Advantage remains a long-term tailwind, and CenterWell coordinated care isn't priced into Humana's strategy. I maintain buy rating at a price target of $370, 28% upside.
Neutral
Business Wire
2 weeks ago
AM Best Downgrades Credit Ratings of Humana Health of Puerto Rico Group's Subsidiaries; Affirms Credit Ratings of Humana Inc. and Most of Its Health Insurance Subsidiaries
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has downgraded the Financial Strength Rating (FSR) to B+ (Good) from B++ (Good) and the Long-Term Issuer Credit Rating (Long-Term ICR) to “bbb-” (Good) from “bbb” (Good) of Humana Insurance of Puerto Rico, Inc. and Humana Health Plans of Puerto Rico, Inc. These companies are domiciled in Puerto Rico and collectively are referred to as Humana Health of Puerto Rico Group. The outlook of these Credit Ratings (ratings) has been revised to negative from stable.
Charts implemented using Lightweight Charts™